Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M44.3Revenue $M3.1Net Margin (%)-1,198.2Altman Z-Score-16.9
Enterprise Value $M22.2EPS $-0.5Operating Margin %-1,284.0Piotroski F-Score3
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-1,198.2Higher ROA y-yY
Price/Book4.010-y EBITDA Growth Rate %-31.9Quick Ratio2.5Cash flow > EarningsN
Price/Sales11.95-y EBITDA Growth Rate %-5.0Current Ratio2.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-89.6Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-210.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M86.5ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with SNSS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SNSSFirst Eagle Investment 2015-06-30 Sold Out $2.07 - $3.01
($2.53)
$ 0.51-80%Sold Out0
SNSSFirst Eagle Investment 2015-03-31 Reduce-0.01%$2.1 - $2.83
($2.4)
$ 0.51-79%Reduce -58.43%587,976
SNSSFirst Eagle Investment 2014-12-31 Buy 0.01%$1.05 - $6.64
($2.06)
$ 0.51-75%New holding1,414,276
SNSSFirst Eagle Investment 2014-09-30 Sold Out -0.0032%$5.55 - $8.23
($6.9)
$ 0.51-93%Sold Out0
SNSSFirst Eagle Investment 2013-09-30 Buy $4.55 - $6.05
($5.08)
$ 0.51-90%New holding200,000
SNSSFirst Eagle Investment 2013-03-31 Sold Out -0.0052%$4 - $6.49
($5.2)
$ 0.51-90%Sold Out0
SNSSFirst Eagle Investment 2012-09-30 Reduce$2.95 - $5.76
($3.55)
$ 0.51-86%Reduce -30.24%350,000
SNSSFirst Eagle Investment 2012-06-30 Buy 0.01%$2.51 - $3.18
($2.78)
$ 0.51-82%New holding501,727
SNSSFirst Eagle Investment 2012-03-31 Sold Out -0.0026%$1.17 - $2.87
($1.79)
$ 0.51-72%Sold Out0
SNSSFirst Eagle Investment 2009-12-31 Sold Out $1.8 - $12.54
($3.79)
$ 0.51-87%Sold Out0
SNSSFirst Eagle Investment 2009-06-30 Reduce$0.99 - $3.45
($1.95)
$ 0.51-74%Reduce -90.60%16,667
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SNSS is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


SNSS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Misfeldt DaytonDirector 2015-12-21Buy1,750,000$0.84-39.29view
Swisher Daniel N JRPresident and CEO 2015-08-25Buy25,000$1.01-49.5view
Ketchum Steven BDirector 2015-07-24Sell6,358$3.46-85.26view
BJERKHOLT ERICEVP, CFO & Corp. Secretary 2015-07-24Sell6,358$3.46-85.26view
Swisher Daniel N JRPresident and CEO 2015-07-24Sell12,715$3.46-85.26view
BAY CITY CAPITAL LLC10% Owner 2015-07-24Sell635,702$3.46-85.26view
Misfeldt DaytonDirector 2015-07-24Sell635,702$3.46-85.26view
BARRIS PETER J10% Owner 2014-08-29Sell266,700$7.97-93.6view
BARRETT M JAMES10% Owner 2014-08-29Sell266,700$7.97-93.6view
Growth Equity Opportunities Fu10% Owner 2014-08-29Sell266,700$7.97-93.6view

Quarterly/Annual Reports about SNSS:

News about SNSS:

Articles On GuruFocus.com
Roundys Among Largest Insiders' Buys of the Week Dec 31 2015 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2010 
Weekly CFO Buys Highlight: SNSS, INUV, CEP, CMTL, SURW Oct 09 2010 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 13 2010 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Apr 29 2010 
Hardest Hit Companies of the Day: Transition Therapeutics Inc., Sunesis Pharmaceuticals Inc., GenCor Dec 15 2009 
Most Trade Guru Stocks: Citigroup Inc., Bank of America Corp., Alcoa Inc., Sunesis Pharmaceuticals Dec 12 2009 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 16 2009 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) Jul 28 2009 
Sunesis Pharmaceuticals Inc. Reports Operating Results (10-Q) May 08 2009 

More From Other Websites
Sunesis to Host Conference Call on May 5th to Discuss First Quarter 2016 Financial Results and... Apr 28 2016
Sunesis to Host Conference Call on May 5th to Discuss First Quarter 2016 Financial Results and... Apr 28 2016
SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers Apr 15 2016
SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Apr 06 2016
Edited Transcript of SNSS earnings conference call or presentation 10-Mar-16 4:00pm GMT Apr 06 2016
SUNESIS PHARMACEUTICALS INC Financials Apr 06 2016
Sunesis Pharmaceuticals to Present at the 15th Annual Needham Healthcare Conference Apr 05 2016
Sunesis Pharmaceuticals to Present at the 15th Annual Needham Healthcare Conference Apr 05 2016
Sunesis Pharmaceuticals Announces Closing of $15 Million Venture Loan Apr 01 2016
Sunesis Pharmaceuticals Announces Closing of $15 Million Venture Loan Apr 01 2016
ETF’s with exposure to Sunesis Pharmaceuticals, Inc. : March 29, 2016 Mar 29 2016
SUNESIS PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Mar 28 2016
Sunesis Pharmaceuticals Appoints Geoffrey Parker to the Board of Directors Mar 28 2016
Sunesis Pharmaceuticals Appoints Geoffrey Parker to the Board of Directors Mar 28 2016
Sunesis Pharmaceuticals Announces First Patient Treated in Vanderbilt University-Sponsored Phase 2... Mar 24 2016
Sunesis Pharmaceuticals Announces First Patient Treated in Vanderbilt University-Sponsored Phase 2... Mar 24 2016
Sunesis Pharmaceuticals Announces First Subject Dosed in Phase 1A Healthy Volunteer Study Evaluating... Mar 23 2016
Sunesis Pharmaceuticals Announces First Subject Dosed in Phase 1A Healthy Volunteer Study Evaluating... Mar 23 2016
ETF’s with exposure to Sunesis Pharmaceuticals, Inc. : March 18, 2016 Mar 18 2016
Sunesis Pharmaceuticals, Inc. :SNSS-US: Earnings Analysis: 2015 By the Numbers Mar 17 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)